Cargando…

Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review

BACKGROUND: Clinical trial reports often emphasize efficacy over harms, leading to misinterpretation of the risk‐to‐benefit ratio of new therapies. Clear and sufficiently detailed reporting of methods and results is especially important in the abstracts of trial reports, as readers often base their...

Descripción completa

Detalles Bibliográficos
Autores principales: Komorowski, Adam S., MacKay, Helen J., Pezo, Rossanna C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367648/
https://www.ncbi.nlm.nih.gov/pubmed/32452660
http://dx.doi.org/10.1002/cam4.3095